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Fluorescein angiography (FA) showed early hypofluorescence and late hyperfluorescence due to staining at the level of the lesions. Acute lesions on indocyanine green (ICG) angiography were hypofluorescent. Both revealed a CNV membrane in the OS. (Figures 1 and 2) .
Sarcoidosis, tuberculosis, and presumed ocular histoplasmosis syndrome were excluded. Blood analysis excluded other infectious and inflammatory causes.
The patient received three intravitreal (IVT) injections of ranibizumab in the OS spaced 1 month apart. The CNV membrane disappeared, but 2 months later it reappeared and vision decreased to 20/80. Three additional injections were administered whereby vision stabilized at 20/63. FA was repeated. No leakage was present. However, the ICG showed small hypofluorescent spots within 3 DD of the lesion that suggested inflammatory activity in the choroid. (Figure 3 ).
We performed an IVT injection of 400 mg methotrexate (MTX) in 0.1 ml. Vision improved to 20/25 over 3 months. The vision remained stable with no flare up for over 20 months.
Comment
CNV occurs in up to one third of patients with MFC. Numerous therapies have been proposed, including thermal laser, subretinal surgery, PDT, local and systemic corticosteroids, anti-VEGF therapy, and immunosuppressive agents. 1 IVT MTX, used as chemotherapy, is effective in inducing a clinical remission of intraocular tumor in primary central nervous system lymphoma. 2 MTX has also been used in unilateral intermediate or posterior uveitis, and cystoid macular edema. 3 Its antiinflammatory effect is well known, but it can also decrease VEGF. 4 For instance, Byun et al 5 used topical and subconjunctival MTX for corneal neovascularization with good results. We achieved improved vision and no CNV membrane recurrence by administering IVT MTX. The absence of recurrence can be due to MTX's dual mechanism of action: anti-inflammatory and anti-angiogenic. MTX should be considered as a treatment option for CNV membrane especially in cases with an inflammatory etiology.
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Case report
A 10-year-old boy was diagnosed to have right eye (OD) Coats' disease on routine eye examination. The vision in 
Comments
Coats' disease is a unilateral exudative retinopathy, more commonly seen in males. 1, 2 Retinal photocoagulation/ cryopexy can lead to premacular fibrosis. ERM is a rare cause of visual loss in Coats' disease. In two large case series, ERM was noted in 2.5-4.4% of the cases, 2,3 but there was no mention of any treatment for the ERM. Only one case report, till date, shows good anatomical and visual improvement after vitrectomy and ERM removal in a case of adult onset Coats' disease. 4 There is no report of vitrectomy being performed for secondary ERM in a patient with juvenile Coats'. Our case did well after vitrectomy and ERM removal; thus, patients having ERM should be given the benefit of early surgery.
Eye ( Silicone oil is toxic to the cornea causing endothelial failure and band keratopathy. 1 In traumatic aniridia and aphakia, there lacks a barrier for silicone oil between the posterior and anterior chambers. Therefore, if retinal surgery is also required, silicone oil tamponade may cause the cornea to decompensate unless an artificial barrier can be constructed. We report a novel technique in a patient following globe rupture.
Case report
A 43-year-old male who had previous penetrating keratoplasty for keratoconus endured blunt trauma to his left eye. He had total iris loss and required a repeat penetrating keratoplasty and lensectomy due to the globe rupture. Three weeks later, he had a total retinal detachment with severe proliferative vitreoretinopathy (PVR). He underwent pars plana vitrectomy, retinectomy, PVR membrane peel, laser, and silicone oil tamponade. Before silicone oil injection, 360-degree conjunctival peritomy was performed, and an artificial barrier was formed using a continuous 10/0 prolene suture (Ethicon W1713, Somerville, NJ, USA) placed 2.5 mm from the corneal limbus ( Figure 1a) . Within 2 months, he developed a membrane at the level of the retention suture, seperating the silicone oil from the anterior chamber. Laser capsulotomy was initially planned, but he subsequently spontaneously developed a central opening within the membrane (Figure 1b) . His retina remained flat under oil, and visual acuity at 4 months follow-up was counting fingers.
Discussion
Retention sutures are effective in preventing corneal decompensation in aniridic eyes requiring silicone oil tamponade. 2 This is because of the surface tension of silicone oil and its propensity to stay as a single bubble within the vitreous cavity. The method described above allows for one continuous suture to be used in forming the barrier, and is an alternative to the previously described technique using multiple sutures. It is not known if the hexagonal shape is better than others at stimulating peri-silicone proliferation and membrane formation, 3 the rate of which may also vary between patients and with topical steroid use. In our case, an opening in the membrane formed spontaneously, but in others, laser capsulotomy may be required. 
